Study on metabolism of estrogen tablet in postmenopausal women with end stage renal failure receiving perttoneal dialysis

SUN Wan-hui,BAI Wen-pei,MAO Guang-ping,WANG Tao,HU Jian-ying,SUN Pei-hong,WANG Lan,CHANG Hong,ZHANG Xiao-qun

DOI: https://doi.org/10.3969/j.issn.1001-6821.2007.01.003

2007-01-01

Abstract:Objective To investigate the metabolism of estrogen on postmenopausal women with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD). Methods Six postmenopausal females with ESRD receiving PD(trial)and six postmenopausal females with normal renal function (control) were involved in this study. Blood samples were collected at the time after orally of estradiol (E_2) at a single dose 1 mg. Urine samples of all the subjects were collected in the same way with PD. E_ 2 concentrations in both two groups were determined. Albumin, sex-hormone binding globulin (SHBG), luteinizint hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), progesterone (P) and prolactin (PRL) in serum were determined at the time of 0, 72 h.Results Peak serum concentrations of E_2 in trial were higher than the control. Total clearance of E_2 in ESRD subjects of trial was lower than the control. Albumin and SHBG in trial before and after administration was significant lower than control. Albumin, SHBG, LH, FSH, E_2, T and P at the time of 0, 72 h were similar with the two groups. While PRL in trial was higher than the control.Conclusion The accumulation was found in trial after oral E_2 with they receiving PD. So this populations should be recommended smaller dosage, maybe half of the dose in a long term treatment.